Aqeel Hussain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Aqeel Hussain has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Alkesh Kumar Khurana
Head of the Department of Pulmonary Medicine & TB, All India Institute of Medical Sciences (AIIMS), Bhopal, Madhya Pradesh, 462020, India
5 shared publications - Abhishek Goyal
Department of Pulmonary Medicine, AIIMS, Bhopal, Madhya Pradesh, India
4 shared publications Raj Krishnan Soman
Pulmonary, Critical Care & Sleep Medicine, AIIMS Bhopal, India
2 shared publications- Raj Krishnan Soman
Department of Pulmonary Medicine, AIIMS, Bhopal, Madhya Pradesh, India
2 shared publications - Sunaina Tejpal Karna
Department of Anesthesiology, All India Institute of Medical Sciences Bhopal, Bhopal, India
2 shared publications - Ujjawal Khurana
Department of Pathology and Lab Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
2 shared publications
Latest Publications
- Open Access
- 16 March 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (2)
Shankh blowing in obstructive sleep apnoea: something special or a routine respiratory exercise?
We read with great interest the article by Sharma et al. [1] whereby they have performed a randomised controlled trial to evaluate the effect of Shankh (conch shell) blowing on patients with moderate sleep apnoea. However, we feel some issues need to be addressed apart from the ones mentioned by the authors themselves in their discussion of the limitations of the study.
- 16 March 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (2)
Open AccessShankh blowing in obstructive sleep apnoea: something special or a routine respiratory exercise?
We read with great interest the article by Sharma et al. [1] whereby they have performed a randomised controlled trial to evaluate the effect of Shankh (conch shell) blowing on patients with moderate sleep apnoea. However, we feel some issues need to be addressed apart from the ones mentioned by the authors themselves in their discussion of the limitations of the study.
- 11 April 2023
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 71 (2) , 123-129
Effect of pulmonary rehabilitation in patients with post-tuberculosis sequelae with functional limitation
- 11 April 2023
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 71 (2) , 123-129
Effect of pulmonary rehabilitation in patients with post-tuberculosis sequelae with functional limitation
- Open Access
- 1 March 2022
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 23 (2) , 89-96
Six-Week Hospital-Based Pulmonary Rehabilitation in Covid Pneumonia ICU Survivors: Experience from a Tertiary Care Center in Central India
ARDS,COVID,exercise capacity,pulmonary rehabilitation,quality of life
- 1 March 2022
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 23 (2) , 89-96
Open AccessSix-Week Hospital-Based Pulmonary Rehabilitation in Covid Pneumonia ICU Survivors: Experience from a Tertiary Care Center in Central India
ARDS,COVID,exercise capacity,pulmonary rehabilitation,quality of life
- Open Access
- 17 January 2022
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 26 (1) , 85-93
Weaning Outcomes and 28-day Mortality after Tracheostomy in COVID-19 Patients in Central India: A Retrospective Observational Cohort Study
Background: Tracheostomy is integral in long-term intensive care of coronavirus disease-2019 (COVID-19) patients. There is a paucity of studies on weaning outcomes and mortality after tracheostomy in COVID-19 in Indian scenario. Materials and methods: We conducted a retrospective, single-center, observational study of severe COVID-19 patients who underwent elective tracheostomy (n = 65) during critical care in a tertiary care institute in Central India from May 1, 2020, to April 30, 2021. Data were collected from Medical records, ICU charts, and follow-up visits by patient. A primary objective was to study the clinical characteristics, tracheostomy complications, weaning outcomes, and mortality at 28 and 60 days of ICU admission. We categorized the cohort into two groups (deceased and survivor) and studied association of clinical parameters with 28-day mortality. Cox Proportional regression analysis was applied to calculate the hazard ratio among the predictors of mortality with p value <0.05 as significant. Results: Elective tracheostomy was done in 69 of 436 (15.8%) patients on invasive mechanical ventilation, of which 65 were included. Tracheostomy was percutaneous in 45/65 (69%) and surgical in 20/65 (31%) with timing from intubation as early in 41/65 and late in 24/65 with most common indication as weaning failure followed by anticipated prolonged ventilation. Tracheostomy complications were present in 29/65 (45%) patients with no difference in complication rates between timing and type of tracheostomy. Downsizing, decannulation, and weaning were successful in 22%, 32 (49%), and 35/65 (54%) patients after tracheostomy. The 28-day mortality was 30/65 (46%). The fractional inspired oxygen concentration (FiO(2)) requirement in survivors was lower (0.4-0.6, p = 0.015) with a higher PaO2/FiO(2) ratio (118-200, p = 0.033). Early tracheostomy within 7 days of intubation was not associated with weaning or survival benefit. Conclusions: We suggest that tracheostomy should be delayed to after 7 days of intubation, especially till FiO(2) reduces to 0.5 with improvement in PaO2/FiO(2) for better outcomes and avoiding a wasted procedure (CTRI/2021/07/034768).
- 17 January 2022
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 26 (1) , 85-93
Open AccessWeaning Outcomes and 28-day Mortality after Tracheostomy in COVID-19 Patients in Central India: A Retrospective Observational Cohort Study
Background: Tracheostomy is integral in long-term intensive care of coronavirus disease-2019 (COVID-19) patients. There is a paucity of studies on weaning outcomes and mortality after tracheostomy in COVID-19 in Indian scenario. Materials and methods: We conducted a retrospective, single-center, observational study of severe COVID-19 patients who underwent elective tracheostomy (n = 65) during critical care in a tertiary care institute in Central India from May 1, 2020, to April 30, 2021. Data were collected from Medical records, ICU charts, and follow-up visits by patient. A primary objective was to study the clinical characteristics, tracheostomy complications, weaning outcomes, and mortality at 28 and 60 days of ICU admission. We categorized the cohort into two groups (deceased and survivor) and studied association of clinical parameters with 28-day mortality. Cox Proportional regression analysis was applied to calculate the hazard ratio among the predictors of mortality with p value <0.05 as significant. Results: Elective tracheostomy was done in 69 of 436 (15.8%) patients on invasive mechanical ventilation, of which 65 were included. Tracheostomy was percutaneous in 45/65 (69%) and surgical in 20/65 (31%) with timing from intubation as early in 41/65 and late in 24/65 with most common indication as weaning failure followed by anticipated prolonged ventilation. Tracheostomy complications were present in 29/65 (45%) patients with no difference in complication rates between timing and type of tracheostomy. Downsizing, decannulation, and weaning were successful in 22%, 32 (49%), and 35/65 (54%) patients after tracheostomy. The 28-day mortality was 30/65 (46%). The fractional inspired oxygen concentration (FiO(2)) requirement in survivors was lower (0.4-0.6, p = 0.015) with a higher PaO2/FiO(2) ratio (118-200, p = 0.033). Early tracheostomy within 7 days of intubation was not associated with weaning or survival benefit. Conclusions: We suggest that tracheostomy should be delayed to after 7 days of intubation, especially till FiO(2) reduces to 0.5 with improvement in PaO2/FiO(2) for better outcomes and avoiding a wasted procedure (CTRI/2021/07/034768).
- Open Access
- 25 November 2021
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 21 (4) , 664-665
Askin’s Tumour: Massive tumour with minimal symptoms
- 25 November 2021
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 21 (4) , 664-665
Open AccessAskin’s Tumour: Massive tumour with minimal symptoms
- 18 October 2021
- Published by Wiley in Diagnostic Cytopathology
- Vol. 50 (2) , E59-E62
Cytologic and flowcytometric findings in a case of myelomatous pleural effusion: A rare and ominous presentation of multiple myeloma
Plasma cell myeloma is a hematologic malignancy characterized by multifocal clonal proliferation of plasma cells usually associated with M protein secretion in serum and/or urine and evidence of organ damage. Generally, the presenting features are related to anemia, bone lesions, and renal failure. Pleural effusion is rare in multiple myeloma and when present is often due to nonmalignant causes. Myelomatous pleural effusion that is, effusions directly due to pleural infiltration by plasma cells is even rarer. We present a case of a patient presenting with dyspnea due to myelomatous pleural effusion. The fluid in such a case may be subjected to cytology examination, protein electrophoresis, flowcytometric analysis, and cytogenetics. The case highlights the utility of cytomorphology and flowcytometry in the diagnosis of myelomatous pleural effusion and also highlights that this type of presentation portends a poor prognosis to the patient.
- 18 October 2021
- Published by Wiley in Diagnostic Cytopathology
- Vol. 50 (2) , E59-E62
Cytologic and flowcytometric findings in a case of myelomatous pleural effusion: A rare and ominous presentation of multiple myeloma
Plasma cell myeloma is a hematologic malignancy characterized by multifocal clonal proliferation of plasma cells usually associated with M protein secretion in serum and/or urine and evidence of organ damage. Generally, the presenting features are related to anemia, bone lesions, and renal failure. Pleural effusion is rare in multiple myeloma and when present is often due to nonmalignant causes. Myelomatous pleural effusion that is, effusions directly due to pleural infiltration by plasma cells is even rarer. We present a case of a patient presenting with dyspnea due to myelomatous pleural effusion. The fluid in such a case may be subjected to cytology examination, protein electrophoresis, flowcytometric analysis, and cytogenetics. The case highlights the utility of cytomorphology and flowcytometry in the diagnosis of myelomatous pleural effusion and also highlights that this type of presentation portends a poor prognosis to the patient.
- Open Access
- 8 July 2021
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 7 (3) , 00398-2021
Pulmonary rehabilitation in COVID-19 pneumonia sequelae: so near yet so far
We read with great interest the article by Gloeckl et al. whereby they have done an interesting study to evaluate the effect and feasibility of Pulmonary Rehabilitation (PR) in Covid patients [1]. However, we feel that a few pertinent issues need to be highlighted and addressed. Covid-19 associated chronic health issues can persist for prolonged period after recovery from acute illness and has been termed as long covid. However the literature suggests that CT changes and associated lung function impairment show resolution with time [2].
- 8 July 2021
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 7 (3) , 00398-2021
Open AccessPulmonary rehabilitation in COVID-19 pneumonia sequelae: so near yet so far
We read with great interest the article by Gloeckl et al. whereby they have done an interesting study to evaluate the effect and feasibility of Pulmonary Rehabilitation (PR) in Covid patients [1]. However, we feel that a few pertinent issues need to be highlighted and addressed. Covid-19 associated chronic health issues can persist for prolonged period after recovery from acute illness and has been termed as long covid. However the literature suggests that CT changes and associated lung function impairment show resolution with time [2].
- 7 June 2021
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 22 (3) , 271-273
Primary Pulmonary Marginal Cell Lymphoma: Your Eyes See Only What Your Mind Knows
Lung cancer,marginal zone lymphoma,primary pulmonary lymphoma (ppl),tuberculosis,EBUS
- 7 June 2021
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 22 (3) , 271-273
Primary Pulmonary Marginal Cell Lymphoma: Your Eyes See Only What Your Mind Knows
Lung cancer,marginal zone lymphoma,primary pulmonary lymphoma (ppl),tuberculosis,EBUS